JOVANA
Library Glossary Getting Started Three Levels Fields How it works Mission
Join the mission
All guides

Dominant Disorders: When One Copy Is Enough

Huntington disease and achondroplasia need only one faulty copy to cause the disease. Why does the good copy fail to rescue you here? Meet gain-of-function and dominant-negative effects, and the 50% transmission rule.

One bad copy is the whole story

In an autosomal dominant disorder, a single faulty copy is enough to cause disease, even though a perfectly good copy sits right beside it. The disease allele is a dominant allele — written D — so genotypes Dd and DD are both affected, and only dd is unaffected. Huntington disease and achondroplasia are textbook examples.

Why doesn't the good copy save the day, as it does in recessive disease? Usually because the fault is not a simple loss of function. In a gain-of-function mutation, the altered protein actively does harm — in Huntington disease, a misfolded protein accumulates and poisons neurons, and no amount of normal protein can mop it up. In a dominant-negative effect, the bad protein jams the machinery the good copies are trying to build. Either way, having one good copy is not enough.

The 50% rule

Because an affected person is usually heterozygous (Dd), each child has a one-in-two chance of inheriting the disease allele. The cross is Dd x dd, and the Punnett square is strikingly simple.

Cross: Dd  x  dd   (affected parent  x  unaffected parent)

          affected parent
          |  D  |  d
      ----+-----+-----
   un  d  | Dd  | dd
   aff     |     |
   ----+-----+-----
   par  d  | Dd  | dd
   ent     |     |

Children:  1/2 Dd (AFFECTED)  :  1/2 dd (unaffected)

=> 50% of children inherit the disorder, each pregnancy.
   The trait appears in EVERY generation (vertical pedigree).
   Unaffected children (dd) cannot pass it on.
Affected (Dd) x unaffected (dd): a 50% chance of an affected child each pregnancy, appearing every generation.

Not everyone shows it the same way

Dominant does not mean rigidly predictable. Penetrance asks: of everyone carrying the allele, what fraction actually show any sign of the disease? When penetrance is below 100%, a carrier can stay symptom-free yet still pass the allele on — so a disorder can appear to “skip” a generation. Expressivity asks a different question: among those who are affected, how strongly? Some show mild signs, others severe. These two ideas explain much of the variability families notice.